Victor Lobanenkov

Chief, Molecular Pathology Section, Division of Intramural Research, NIAID, NIH
Summary
Victor Lobanenkov is a renowned researcher with over 30 years of experience in CTCF studies and molecular cloning.
His work has led to the identification and purification of the 'CCCTC binding nuclear Factor' in birds, mice, and humans, with patented and published findings dating back over two decades.
Victor Lobanenkov has highlighted the unique ability of CTCF to recognize multiple DNA sequences through its 'multivalent' 11 Zinc Finger Domain, conserved across various species.
In addition to his contributions to understanding the universal functions of chromosomal and centrosomal CTCF, he has also discovered the CTCF-Like Paralogue named B.O.R.I.S., emphasizing the Normal and Pathologic Functions of both CTCF and BORIS genes.
His research has focused on the co-evolved 11 Zinc Finger Domains shared by somatic CTCF and testis-specific BORIS genes, shedding light on their binding to dissimilar regulatory DNA sequences.
Victor Lobanenkov's efforts have revealed the presence of dual CTCF Target Sites, showing the simultaneous DNA-co-occupancy by CTCF and BORIS in specific genomic regions.
He has served in key roles at prestigious institutions including the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and the Fred Hutchinson Cancer Research Center.
His educational background includes a Bachelor of Applied Science in Experimental Nuclear Physics from the Moscow Institute of Nuclear Physics and Engineering, as well as a High School Diploma in Mathematical Statistics and Probability from the Special School of Mathematics and Physics in Moscow.